Emerging paradigms propose cardiac-specific oxidative modifications as potential biomarkers—for instance, oxidative adducts on cardiac myosin binding protein-C (cMyBP-C) have been implicated in diastolic heart failure [44]. The gene discussed is MYBPC3; the disease is diastolic heart failure.